Alzheimer's Study

Study Purpose: To investigate the effects of daily dosing of study medication vs. placebo on cognitive function in subjects with mild to moderate Alzheimer's disease.

Basic Eligibility Criteria:

• Patients 50-88 years old
• Clinical diagnosis of probable Alzheimer’s disease
• Subject has a regular caregiver who is willing to attend all visits

Alzheimer's Study

Study Purpose: To investigate the effects of study drug in patients with mild to moderate Alzheimer's Disease.

Basic Eligibility Criteria:

• Patients at least 55 years old
• Has a reliable caregiver who is in frequent contact with the patient
• Has a clinical diagnosis of mild to moderate AD

Clinical Trials
Alzheimer's	Back Pain
Depression	Diabetic Neuropathy
Fibromyalgia	Migraines
Multiple Sclerosis	Optic Neuritis
Overactive Bladder	Parkinson's Disease
Partial Seizures	Spasticity
Spinal Cord Injury	Stroke

If you would like further information about any of our Clinical Trials at Associated Neurologists of Southern Connecticut, please feel free to contact any of our Research staff:

Angelo Termine, Clinical Research Manager, at atermine@anscneuro.com

Amanda Herrera, Clinical Research Administrative Assistant, at aherrera@anscneuro.com 

or any of our Clinical Research Coordinators: 

Sharon Kingson at skingson@anscneuro.com

Elizabeth Perrotti at eperrotti@anscneuro.com

Grace Castaneda at gcastaneda@anscneuro.com 

Cindy Chu at cchu@anscneuro.com or

Amanda Lemieux at alemieux@anscneuro.com

You may also call 203.333.1151 and we will be happy to answer any of your questions.